JIASHILI GP (01285) released its interim results, with a profit attributable to shareholders of 60.58 million yuan, representing a year-on-year increase of 412.51%.

21:07 31/08/2026

Jasli Group (01285) announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 810 million, an increase of 8.04% year-on-year; profit attributable to owners of Jasli Group Limited was RMB 60.558 million, an increase of 412.51% year-on-year; earnings per share were 14.59 cents; and a mid-term dividend of 10.00 Hong Kong cents was declared.

JIASHILI GP (01285) announced its interim results for the six months ended June 30, 2026, reporting revenue of RMB 810 million, an increase of 8.04% year-on-year; the profit attributable to owners of JIASHILI GP Limited was RMB 60.558 million, a year-on-year increase of 412.51%; earnings per share were 14.59 cents; an interim dividend of 10.00 Hong Kong cents was declared.

KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.

Gelin Biological (301688.SZ) stock will be listed on the ChiNext board on September 2.

KAISA GROUP (01638) announced its interim results, with a loss attributable to shareholders of approximately 9.3285 billion yuan, a year-on-year decrease of about 7%.

EDA GROUP HLDGS (02505) released its interim results, reporting a net loss attributable to shareholders of 42.16 million yuan, compared to a profit in the same period last year.

Gelin Biological (301688.SZ) stock will be listed on the ChiNext board on September 2.